IBDEI0NH ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10572,1,3,0)
 ;;=3^Bipolar & Related Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,10572,1,4,0)
 ;;=4^F31.89
 ;;^UTILITY(U,$J,358.3,10572,2)
 ;;=^5003520
 ;;^UTILITY(U,$J,358.3,10573,0)
 ;;=F31.9^^42^471^5
 ;;^UTILITY(U,$J,358.3,10573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10573,1,3,0)
 ;;=3^Bipolar & Related Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,10573,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,10573,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,10574,0)
 ;;=A81.00^^42^472^8
 ;;^UTILITY(U,$J,358.3,10574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10574,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,10574,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,10574,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,10575,0)
 ;;=A81.09^^42^472^7
 ;;^UTILITY(U,$J,358.3,10575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10575,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,10575,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,10575,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,10576,0)
 ;;=A81.2^^42^472^73
 ;;^UTILITY(U,$J,358.3,10576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10576,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,10576,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,10576,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,10577,0)
 ;;=F01.50^^42^472^47
 ;;^UTILITY(U,$J,358.3,10577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10577,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10577,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,10577,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,10578,0)
 ;;=F01.51^^42^472^48
 ;;^UTILITY(U,$J,358.3,10578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10578,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10578,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,10578,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,10579,0)
 ;;=F02.80^^42^472^35
 ;;^UTILITY(U,$J,358.3,10579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10579,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10579,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10579,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10580,0)
 ;;=F02.81^^42^472^36
 ;;^UTILITY(U,$J,358.3,10580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10580,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10580,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10580,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10581,0)
 ;;=G30.9^^42^472^4
 ;;^UTILITY(U,$J,358.3,10581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10581,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,10581,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,10581,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,10582,0)
 ;;=G31.01^^42^472^71
 ;;^UTILITY(U,$J,358.3,10582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10582,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,10582,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,10582,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,10583,0)
 ;;=G94.^^42^472^6
 ;;^UTILITY(U,$J,358.3,10583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10583,1,3,0)
 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,10583,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,10583,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,10584,0)
 ;;=G31.83^^42^472^18
